Needle-free connectors catheter-related bloodstream infections: a prospective randomized controlled trial

Michael Koeppen, Franziska Weinert, Sabrina Oehlschlaeger, Andreas Koerner, Peter Rosenberger, Helene Anna Haeberle, Michael Koeppen, Franziska Weinert, Sabrina Oehlschlaeger, Andreas Koerner, Peter Rosenberger, Helene Anna Haeberle

Abstract

Background: In the critically ill, catheter-related bloodstream infection can result from bacterial contamination of infusion hubs of intravascular catheters. Needle-free connectors (NFC) have been suggested to reduce the rate of bacterial contamination and subsequent catheter-related bloodstream infection (CRBSI), but data remains ambiguous. Thus, we tested if a novel NFC would reduce bacterial contamination and subsequent CRBSI.

Results: In a prospective, randomized controlled trial, surgical ICU patients were randomized to three-way hubs closed by caps or Bionecteur® (Vygon, Inc.) of central venous catheters. Every 72 h, infusion lines were renewed and microbiological samples were taken. Bacterial growth was analyzed by blinded microbiologists. Incidence of bacterial contamination and CRSBI were assessed. Outcome parameters like length of stay on ICU and outcome were retrospectively assessed. Two thousand seven hundred patients were screened, 111 were randomized to the NFC, and 109 into the control group. Finally, 24 patients in the NFC and 23 control patients were analyzed. The majority of samples (NFC 77%; control 70%) found no bacterial growth. Coagulase-negative staphylococci were most commonly detected on CVC samples (NFC 17%; control 21%). We found CRBSI (defined as identical pathogens in blood culture and catheter line tip culture, and clinical manifestations of infection) in two control patients and one patient of the NFC group. Their length of ICU stay did not differ between groups (NFC 19 days; control 23 days).

Conclusion: The use of NFC does not influence the rate of bacterial contamination of infusion hubs of central venous catheters.

Trial registration: Clinicaltrials.gov, NCT02134769. Registered 09 May 2014.

Keywords: Bionecteur®; Catheter-related bloodstream infections; Needle-free connectors.

Conflict of interest statement

Vygon® provided Bionecteur® needle-free connectors free of charge for this study. Vygon Inc. had no influence on or participated in patient selection, data acquisition, data analysis or the writing of the manuscript.

Figures

Fig. 1
Fig. 1
Flow chart of screening and randomization
Fig. 2
Fig. 2
Setup of entry port connectors. a Arterial connection before the implementation of NFC; b CVC connection before the implementation of NFC including stopcocks and caps; c Arterial connection including Bionecteur; d CVC connection using Bionecteur including stopcocks and no caps. Arrow marks CVC line
Fig. 3
Fig. 3
Bacterial contamination of entry ports. Percent of the bacterial growth of entry port sampling during sampling period

References

    1. Lutz P, Strassburg CP. Infektionen unter medikamentöser Immunsuppression bei transplantierten Intensivpatienten. Intensivmedup2date. 2018;14(02):167–182.
    1. Templeton A, Schlegel M, Fleisch F, Rettenmund G, Schobi B, Henz S, Eich G. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study. Infect. 2008;36(4):322–327. doi: 10.1007/s15010-008-7314-x.
    1. Prävention von Infektionen, die von Gefäßkathetern ausgehen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2017, 60(2):216-230.
    1. Trautmann Matthias KM, Radmilla B. Disinfection of a needleless connector with alcohol-based disinfectant wipes – an experimental study. Hyg Med. 2012;37(9):5.
    1. Slater K, Fullerton F, Cooke M, Snell S, Rickard CM. Needleless connector drying time-how long does it take? Am J Infect Control. 2018;46(9):1080–1081. doi: 10.1016/j.ajic.2018.05.007.
    1. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45. doi: 10.1086/599376.
    1. Timsit JF, Rupp M, Bouza E, Chopra V, Karpanen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, et al. A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill. Intensive Care Med. 2018;44(6):742–759. doi: 10.1007/s00134-018-5212-y.
    1. Parienti JJ, Mongardon N, Mégarbane B, Mira JP, Kalfon P, Gros A, Marqué S, Thuong M, Pottier V, Ramakers M, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373(13):1220–1229. doi: 10.1056/NEJMoa1500964.
    1. German National Reference Center for the Surveillance of nosocomial infections (2019) KISS Krankenhaus-Infektions-Surveillance System Modul ITS-KISS. . Accessed 20 June 2019.
    1. Holroyd JL, Paulus DA, Rand KH, Enneking FK, Morey TE, Rice MJ. Universal intravenous access cleaning device fails to sterilize stopcocks. Anesth Analg. 2014;118(2):333–343. doi: 10.1213/ANE.0000000000000059.
    1. Kampf G. Biocidal Agents Used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics (Basel) 2018;7(4):110. doi: 10.3390/antibiotics7040110.
    1. Wand ME, Bock LJ, Bonney LC, Sutton JM. Mechanisms of Increased resistance to chlorhexidine and cross-resistance to colistin following exposure of klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother. 2017;61(1):e01162–e01116. doi: 10.1128/AAC.01162-16.
    1. Esteve F, Pujol M, Limon E, Saballs M, Argerich MJ, Verdaguer R, Manez R, Ariza X, Gudiol F. Bloodstream infection related to catheter connections: a prospective trial of two connection systems. J Hosp Infect. 2007;67(1):30–34. doi: 10.1016/j.jhin.2007.05.021.
    1. Cimiotti JP, Aiken LH, Sloane DM, Wu ES. Nurse staffing, burnout, and health care-associated infection. Am J Infect Control. 2012;40(6):486–490. doi: 10.1016/j.ajic.2012.02.029.
    1. Maragakis LL, Bradley KL, Song X, Beers C, Miller MR, Cosgrove SE, Perl TM. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. 2006;27(1):67–70. doi: 10.1086/499166.
    1. Danzig LE, Short LJ, Collins K, Mahoney M, Sepe S, Bland L, Jarvis WR. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA. 1995;273(23):1862–1864. doi: 10.1001/jama.1995.03520470070034.
    1. Wheeler DS, Giaccone M, Hutchinson N, Haygood M, Demmel K, Britto MT, Margolis PA, Provost LP. An unexpected increase in catheter-associated bloodstream infections at a children's hospital following introduction of the Spiros closed male connector. Am J Infect Control. 2012;40(1):48–50. doi: 10.1016/j.ajic.2011.02.015.
    1. Casey AL, Karpanen TJ, Nightingale P, Elliott TS. The risk of microbial contamination associated with six different needle-free connectors. Br J Nurs. 2018;27(2):S18–S26. doi: 10.12968/bjon.2018.27.2.S18.
    1. Cole DC, Baslanti TO, Gravenstein NL, Gravenstein N. Leaving more than your fingerprint on the intravenous line: a prospective study on propofol anesthesia and implications of stopcock contamination. Anesth Analg. 2015;120(4):861–867. doi: 10.1213/ANE.0b013e318292ed45.
    1. Yebenes JC, Vidaur L, Serra-Prat M, Sirvent JM, Batlle J, Motje M, Bonet A, Palomar M. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control. 2004;32(5):291–295. doi: 10.1016/j.ajic.2003.12.004.
    1. Casey AL, Burnell S, Whinn H, Worthington T, Faroqui MH, Elliott TS. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect. 2007;65(3):212–218. doi: 10.1016/j.jhin.2006.09.029.

Source: PubMed

3
Subscribe